Related Experiment Video
Updated: Apr 14, 2026

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload
Masanori Sano1, Tohru Minamino, Haruhiro Toko
1Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
Insights
Cardiac hypertrophy adaptation involves blood vessel growth (angiogenesis). However, p53 accumulation disrupts this process, leading to heart failure. Promoting angiogenesis can restore heart function.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Heart Failure Pathophysiology
Background:
- Cardiac hypertrophy is an adaptive response to increased workload, but prolonged hypertrophy leads to heart failure.
- The precise mechanisms driving the transition from cardiac hypertrophy to heart failure remain largely unknown.
Purpose of the Study:
- To investigate the role of cardiac angiogenesis in adaptive hypertrophy.
- To elucidate the involvement of p53 in the progression from cardiac hypertrophy to heart failure.
Main Methods:
- Utilized a pressure overload model to induce cardiac hypertrophy.
- Investigated the role of hypoxia-inducible factor-1 (Hif-1) and angiogenic factors in cardiac vascularization.
- Examined the impact of p53 accumulation on angiogenesis and cardiac function.
Main Results:
- Pressure overload initially stimulated cardiac angiogenesis via Hif-1-dependent pathways.
- Inhibition of angiogenesis exacerbated systolic dysfunction during hypertrophy.
- Sustained pressure overload led to p53 accumulation, inhibiting Hif-1 and impairing angiogenesis.
- Enhancing angiogenesis or inhibiting p53 improved cardiac function under chronic pressure overload.
Conclusions:
- Cardiac angiogenesis is critical for the adaptive response to hypertrophy.
- p53 accumulation plays a key role in the transition to heart failure by inhibiting angiogenesis.
- Targeting p53 or promoting angiogenesis may offer therapeutic strategies for heart failure.
Abstract:
Cardiac hypertrophy occurs as an adaptive response to increased workload to maintain cardiac function. However, prolonged cardiac hypertrophy causes heart failure, and its mechanisms are largely unknown. Here we show that cardiac angiogenesis is crucially involved in the adaptive mechanism of cardiac hypertrophy and that p53 accumulation is essential for the transition from cardiac hypertrophy to heart failure. Pressure overload initially promoted vascular growth in the heart by hypoxia-inducible factor-1 (Hif-1)-dependent induction of angiogenic factors, and inhibition of angiogenesis prevented the development of cardiac hypertrophy and induced systolic dysfunction. Sustained pressure overload induced an accumulation of p53 that inhibited Hif-1 activity and thereby impaired cardiac angiogenesis and systolic function. Conversely, promoting cardiac angiogenesis by introducing angiogenic factors or by inhibiting p53 accumulation developed hypertrophy further and restored cardiac dysfunction under chronic pressure overload. These results indicate that the anti-angiogenic property of p53 may have a crucial function in the transition from cardiac hypertrophy to heart failure.
More Related Videos
06:47A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure
Published on: November 29, 2018
07:13A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
Related Concept Videos
Abnormal Proliferation
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Myocarditis I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy